STATE STREET CORP - BELLEROPHON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$5,000
-28.6%
13,8000.0%0.00%
Q3 2019$7,000
-12.5%
13,8000.0%0.00%
Q2 2019$8,000
-11.1%
13,8000.0%0.00%
Q1 2019$9,000
-18.2%
13,8000.0%0.00%
Q4 2018$11,000
-26.7%
13,8000.0%0.00%
Q3 2018$15,000
-54.5%
13,8000.0%0.00%
Q2 2018$33,000
+13.8%
13,8000.0%0.00%
Q1 2018$29,00013,8000.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KLINSKY STEVEN B 4,859,885$44,614,00020.33%
Senator Investment Group LP 448,679$4,119,0000.04%
HIGHLAND CAPITAL MANAGEMENT LP 162,177$1,489,0000.03%
Baker Brothers Advisors 350,000$3,213,0000.03%
Alyeska Investment Group, L.P. 94,131$864,0000.01%
SABBY MANAGEMENT, LLC 30,000$275,0000.01%
FMR LLC 1,302,070$11,953,0000.00%
MILLENNIUM MANAGEMENT LLC 15,427$142,0000.00%
BlackRock Investment Management, LLC 846$8,0000.00%
GOLDMAN SACHS GROUP INC 17,290$159,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders